The Economic Standard’s white paper on HCQ
https://secureservercdn.net/72.167.242.48/u22.f6f.myftpupload.com/wp-content/uploads/2020/09/HCQWhitePaper.pdf
https://secureservercdn.net/72.167.242.48/u22.f6f.myftpupload.com/wp-content/uploads/2020/09/HCQWhitePaper.pdf
I wrote an extremely popular article in April. It got over 50,000 views on Substack, and was republished by Dr. Mercola, Technocracy News and the Epoch Times. In it, I marshalled a great deal of evidence to support the supposition that the COVID vaccines were on their way out, although I anticipated that the cabal…
An interview with my favorite scientist, Dr John Ioannidis (excerpts below), discusses the problem of bogus medical and scientific findings, which are now ubiquitous– as the standards are low and the funders have come to view many of the studies they fund as marketing. John Ioannidis is perhaps best known for a 2005 paper “Why Most…
Does this case hinge on the first samples Ivins gave to the FBI, of which one was sent to Dr. Paul Keim in Arizona? Why does that sample matter, if the flask the FBI later confiscated had the same strain and genetic variability? Furthermore, if Keim’s sample is critical to the case, one must ask,…
https://www.youtube.com/watch?v=2zoSSHx9QtA Perhaps in response to this very interesting news report on Pfizer’s fallout with Brazil and Argentina, today’s NY Times did a hit piece on Brazil’s “painfully slow” rollout of its Covid vaccination campaign. And complained about Bolsonaro spending money on “unproven drug treatments” like hydroxychloroquine. Can you imagine, the NYT chortles derisively, that Bolsonaro…
I was told this turnaround occurred the evening of May 13. I have not seen it in the news yet. The school district had been challenged with a lawsuit after announcing a vaccine mandate and passport arrangement for all teachers students and employees of the district. Apparently the LAUSD board and superintendents finally had a…
An excellent article digging into the details of licensing Covid vaccines, by Peter Doshi: Covid-19 vaccines: In the rush for regulatory approval, do we need more data? BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1244 (Published 18 May 2021) After rollout under emergency authorisation, manufacturers of covid-19 vaccines now have their sights on regulatory approval. But what’s the rush, asks Peter Doshi, and is…